Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
Download
Full text for this resource is not available from the Research Repository.
Export
Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Qaradakhi, Tawar, McSweeney, K ORCID: 0000-0003-4146-8251, Ashiana Ali, B, Zulli, Anthony ORCID: 0000-0002-2660-078X and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2021) Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment. Future Microbiology, 16 (4). pp. 205-209. ISSN 1746-0913
Dimensions Badge
Altmetric Badge
Item type | Article |
URI | https://vuir.vu.edu.au/id/eprint/43114 |
DOI | 10.2217/fmb-2021-0018 |
Official URL | https://www.futuremedicine.com/doi/10.2217/fmb-202... |
Subjects | Current > FOR (2020) Classification > 3208 Medical physiology Current > Division/Research > College of Health and Biomedicine |
Keywords | Corona virus, Covid 19, SARS-CoV-1 pandemic response, treatment, Covid 19 treatment |
Citations in Scopus | 18 - View on Scopus |
Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)